Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes

Affiliations

Comment

Milton Packer. Diabetes Care. 2018 Jan.

. 2018 Jan;41(1):11-13.

doi: 10.2337/dci17-0052.

¹ Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX milton.packer@baylorhealth.edu.

No abstract available

Comment on

Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes.
Witte KK, Drozd M, Walker AMN, Patel PA, Kearney JC, Chapman S, Sapsford RJ, Gierula J, Paton MF, Lowry J, Kearney MT, Cubbon RM. Witte KK, et al. Diabetes Care. 2018 Jan;41(1):136-142. doi: 10.2337/dc17-1406. Epub 2017 Oct 5. Diabetes Care. 2018. PMID: 28982651
Short- and Long-term Prognosis of Patients With Acute Heart Failure With and Without Diabetes: Changes Over the Last Three Decades.
van den Berge JC, Constantinescu AA, Boiten HJ, van Domburg RT, Deckers JW, Akkerhuis KM. van den Berge JC, et al. Diabetes Care. 2018 Jan;41(1):143-149. doi: 10.2337/dc17-0544. Epub 2017 Oct 5. Diabetes Care. 2018. PMID: 28982652
The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction.
Sandesara PB, O'Neal WT, Kelli HM, Samman-Tahhan A, Hammadah M, Quyyumi AA, Sperling LS. Sandesara PB, et al. Diabetes Care. 2018 Jan;41(1):150-155. doi: 10.2337/dc17-0755. Epub 2017 Oct 19. Diabetes Care. 2018. PMID: 29051160 Free PMC article. Clinical Trial.